chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 15.0
Sex: M
Vaccine: COVID19
Symptoms: Product administered to patient of inappropriate age
Clinical narrative: Vaccine administered to patient under 18; This spontaneous case was reported by a pharmacist and describes the occurrence of PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (Vaccine administered to patient under 18) in a 15-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 28-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 28-May-2021, the patient experienced PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (Vaccine administered to patient under 18). On 28-May-2021, PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (Vaccine administered to patient under 18) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant product use was not provided by the reporter.  Treatment information was not provided.
Sex: U
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: Fever after the 2nd dose; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (Fever after the 2nd dose) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 vaccination.     No medical history was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced PYREXIA (Fever after the 2nd dose). At the time of the report, PYREXIA (Fever after the 2nd dose) outcome was unknown.            The patient received both scheduled doses of mRNA-1273 prior to the events, therefore action taken with the drug in response to the events was not applicable.  Concomitant product use was not provided by the reporter.  Treatment information was not provided.
Sex: U
Vaccine: COVID19
Symptoms: Burning sensation, Lymphadenopathy, Mass, Pruritus, Rash
Clinical narrative: Rash; Lymph nodes became swollen; Burning; Large itching,rash/lump; Rash/lump where the shot was; This spontaneous case was reported by a consumer and describes the occurrence of BURNING SENSATION (Burning), PRURITUS (Large itching,rash/lump), MASS (Rash/lump where the shot was), RASH (Rash) and LYMPHADENOPATHY (Lymph nodes became swollen) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. unknown) for COVID-19 vaccination.     No Medical History information was reported.    In May 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In May 2021, the patient experienced BURNING SENSATION (Burning), PRURITUS (Large itching,rash/lump), MASS (Rash/lump where the shot was) and LYMPHADENOPATHY (Lymph nodes became swollen). On an unknown date, the patient experienced RASH (Rash). At the time of the report, BURNING SENSATION (Burning), PRURITUS (Large itching,rash/lump), MASS (Rash/lump where the shot was), RASH (Rash) and LYMPHADENOPATHY (Lymph nodes became swollen) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant product use was not provided by the reporter.  Treatment information was not provided.
Age: 45.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Headache, Influenza like illness, Myalgia, Pyrexia
Clinical narrative: Flu like symptoms; A sore arm; Headache; Fever; Chills; Aches; This spontaneous case was reported by a consumer and describes the occurrence of INFLUENZA LIKE ILLNESS (Flu like symptoms), VACCINATION SITE PAIN (A sore arm), HEADACHE (Headache), MYALGIA (Aches) and PYREXIA (Fever) in a 45-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 26-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-May-2021, the patient experienced MYALGIA (Aches). On 27-May-2021, the patient experienced INFLUENZA LIKE ILLNESS (Flu like symptoms), VACCINATION SITE PAIN (A sore arm), HEADACHE (Headache), PYREXIA (Fever) and CHILLS (Chills). At the time of the report, INFLUENZA LIKE ILLNESS (Flu like symptoms), VACCINATION SITE PAIN (A sore arm), HEADACHE (Headache), MYALGIA (Aches), PYREXIA (Fever) and CHILLS (Chills) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product use was not provided by the reporter.  Treatment information was not provided.
Age: 45.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: Flu like symptoms; A sore arm; Headache; Fever; Chills; Aches; This spontaneous case was reported by a consumer and describes the occurrence of INFLUENZA LIKE ILLNESS (Flu like symptoms), VACCINATION SITE PAIN (A sore arm), HEADACHE (Headache), MYALGIA (Aches) and PYREXIA (Fever) in a 45-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 26-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-May-2021, the patient experienced MYALGIA (Aches). On 27-May-2021, the patient experienced INFLUENZA LIKE ILLNESS (Flu like symptoms), VACCINATION SITE PAIN (A sore arm), HEADACHE (Headache), PYREXIA (Fever) and CHILLS (Chills). At the time of the report, INFLUENZA LIKE ILLNESS (Flu like symptoms), VACCINATION SITE PAIN (A sore arm), HEADACHE (Headache), MYALGIA (Aches), PYREXIA (Fever) and CHILLS (Chills) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product use was not provided by the reporter.  Treatment information was not provided.
Sex: U
Vaccine: COVID19
Symptoms: Erythema, Feeling hot, Peripheral swelling
Clinical narrative: My arm has been swollen; Red; Very warm to the touch; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of PERIPHERAL SWELLING (My arm has been swollen), ERYTHEMA (Red) and FEELING HOT (Very warm to the touch) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    In May 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In May 2021, the patient experienced PERIPHERAL SWELLING (My arm has been swollen), ERYTHEMA (Red) and FEELING HOT (Very warm to the touch). At the time of the report, PERIPHERAL SWELLING (My arm has been swollen), ERYTHEMA (Red) and FEELING HOT (Very warm to the touch) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant product use was not provided by the reporter.  Treatment information was not provided.
Sex: F
Vaccine: COVID19
Symptoms: Chills, Feeling abnormal, Influenza like illness, Pyrexia
Clinical narrative: It hit her like a ton of bricks for two days; Flu like symthoms; Fever; Chills; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of FEELING ABNORMAL (It hit her like a ton of bricks for two days), INFLUENZA LIKE ILLNESS (Flu like symthoms), PYREXIA (Fever) and CHILLS (Chills) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced FEELING ABNORMAL (It hit her like a ton of bricks for two days), INFLUENZA LIKE ILLNESS (Flu like symthoms), PYREXIA (Fever) and CHILLS (Chills). At the time of the report, FEELING ABNORMAL (It hit her like a ton of bricks for two days), INFLUENZA LIKE ILLNESS (Flu like symthoms), PYREXIA (Fever) and CHILLS (Chills) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant product use was not provided by the reporter.  Treatment information was not provided.
Age: 56.0
Sex: M
Vaccine: COVID19
Symptoms: Dizziness, Tinnitus, Vaccination site pain
Clinical narrative: Lightheadedness; Ringing in ears; Arm was sore; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (Lightheadedness), TINNITUS (Ringing in ears) and VACCINATION SITE PAIN (Arm was sore) in a 56-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 003b21a and 001c21a) for COVID-19 vaccination.     Concomitant products included LISINOPRIL and ATORVASTATIN for an unknown indication.   On 24-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 21-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 24-Mar-2021, the patient experienced DIZZINESS (Lightheadedness), TINNITUS (Ringing in ears) and VACCINATION SITE PAIN (Arm was sore). On 24-Mar-2021, DIZZINESS (Lightheadedness) and TINNITUS (Ringing in ears) had resolved. On 26-Mar-2021, VACCINATION SITE PAIN (Arm was sore) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Treatment information was not provided.   This case was linked to MOD-2021-186612 (Patient Link).; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
Sex: M
Vaccine: COVID19
Symptoms: Device connection issue, Underdose
Clinical narrative: Some amount of the vaccine has leaked from the syringe; Some amount of the vaccine has leaked from the syringe; This spontaneous case was reported by a consumer and describes the occurrence of UNDERDOSE (Some amount of the vaccine has leaked from the syringe) and DEVICE CONNECTION ISSUE (Some amount of the vaccine has leaked from the syringe) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced UNDERDOSE (Some amount of the vaccine has leaked from the syringe) and DEVICE CONNECTION ISSUE (Some amount of the vaccine has leaked from the syringe). At the time of the report, UNDERDOSE (Some amount of the vaccine has leaked from the syringe) and DEVICE CONNECTION ISSUE (Some amount of the vaccine has leaked from the syringe) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant product use was not provided by the reporter.  Treatment information was not provided.
Age: 69.0
Sex: M
Vaccine: COVID19
Symptoms: Product dose omission issue
Clinical narrative: Greater than 42 days since the first dose; This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (Greater than 42 days since the first dose) in a 69-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 005821A) for COVID-19 vaccination.     No Medical History information was reported.    On 24-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 28-May-2021, the patient experienced PRODUCT DOSE OMISSION ISSUE (Greater than 42 days since the first dose). On 28-May-2021, PRODUCT DOSE OMISSION ISSUE (Greater than 42 days since the first dose) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       It was reported that patient had  not received the second dose and it had been greater than 42 days since their first dose.   Concomitant product use was not provided by the reporter.  Treatment information was not provided.
Sex: F
Vaccine: COVID19
Symptoms: Oral herpes
Clinical narrative: Cold sore; This spontaneous case was reported by a consumer and describes the occurrence of ORAL HERPES (Cold sore) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Apr-2021, the patient experienced ORAL HERPES (Cold sore). The patient was treated with ACYCLOVIR [ACICLOVIR] for Cold sores, at an unspecified dose and frequency. At the time of the report, ORAL HERPES (Cold sore) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medication were not provided.  The patient reported that she did not have a reaction.   Most recent FOLLOW-UP information incorporated above includes: On 08-Jul-2021: Follow up received updated significant information in narrative.
Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: Diarrhoea, Ear pain, Fatigue, Increased appetite, Somnolence
Clinical narrative: Teeth were hurting; Earache; Diarrhea; Very sleepy; Very tired; Really big increase in appetite; This spontaneous case was reported by a consumer and describes the occurrence of TOOTHACHE (Teeth were hurting), EAR PAIN (Earache), DIARRHOEA (Diarrhea), INCREASED APPETITE (Really big increase in appetite) and SOMNOLENCE (Very sleepy) in a 59-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 002C21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Obesity and Arthritis. Concomitant products included RISPERIDONE, METFORMIN, COLECALCIFEROL (VITAMIN D3), LORATADINE, HYDROCHLOROTHIAZIDE, LISINOPRIL (LISINOPRIL HCTZ), ATORVASTATIN and LEVOTHYROXINE for an unknown indication.    On 26-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-May-2021, the patient experienced INCREASED APPETITE (Really big increase in appetite). On 27-May-2021, the patient experienced SOMNOLENCE (Very sleepy) and FATIGUE (Very tired). On an unknown date, the patient experienced TOOTHACHE (Teeth were hurting), EAR PAIN (Earache) and DIARRHOEA (Diarrhea). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency; BENZOCAINE (ORAJEL) at an unspecified dose and frequency and CAFFEINE at an unspecified dose and frequency. At the time of the report, TOOTHACHE (Teeth were hurting), EAR PAIN (Earache), DIARRHOEA (Diarrhea), INCREASED APPETITE (Really big increase in appetite), SOMNOLENCE (Very sleepy) and FATIGUE (Very tired) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       About an hour after the vaccine, the patient noticed a really big increase in her appetite, she was really hungry and ate a lot. The next day, she felt very tired and sleepy and slept all day and all night. Last night, teeth were hurting and  had an earache.
Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: Toothache
Clinical narrative: Teeth were hurting; Earache; Diarrhea; Very sleepy; Very tired; Really big increase in appetite; This spontaneous case was reported by a consumer and describes the occurrence of TOOTHACHE (Teeth were hurting), EAR PAIN (Earache), DIARRHOEA (Diarrhea), INCREASED APPETITE (Really big increase in appetite) and SOMNOLENCE (Very sleepy) in a 59-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 002C21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Obesity and Arthritis. Concomitant products included RISPERIDONE, METFORMIN, COLECALCIFEROL (VITAMIN D3), LORATADINE, HYDROCHLOROTHIAZIDE, LISINOPRIL (LISINOPRIL HCTZ), ATORVASTATIN and LEVOTHYROXINE for an unknown indication.    On 26-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-May-2021, the patient experienced INCREASED APPETITE (Really big increase in appetite). On 27-May-2021, the patient experienced SOMNOLENCE (Very sleepy) and FATIGUE (Very tired). On an unknown date, the patient experienced TOOTHACHE (Teeth were hurting), EAR PAIN (Earache) and DIARRHOEA (Diarrhea). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency; BENZOCAINE (ORAJEL) at an unspecified dose and frequency and CAFFEINE at an unspecified dose and frequency. At the time of the report, TOOTHACHE (Teeth were hurting), EAR PAIN (Earache), DIARRHOEA (Diarrhea), INCREASED APPETITE (Really big increase in appetite), SOMNOLENCE (Very sleepy) and FATIGUE (Very tired) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       About an hour after the vaccine, the patient noticed a really big increase in her appetite, she was really hungry and ate a lot. The next day, she felt very tired and sleepy and slept all day and all night. Last night, teeth were hurting and  had an earache.
Sex: U
Vaccine: COVID19
Symptoms: Vaccination complication
Clinical narrative: Side effects; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (Side effects) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION COMPLICATION (Side effects). At the time of the report, VACCINATION COMPLICATION (Side effects) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medication was not provided.  Treatment information was not provided.
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Pyrexia, Vomiting
Clinical narrative: vomiting; pain in her joints; fever; This spontaneous case was reported by a consumer and describes the occurrence of VOMITING (vomiting), ARTHRALGIA (pain in her joints) and PYREXIA (fever) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VOMITING (vomiting), ARTHRALGIA (pain in her joints) and PYREXIA (fever). At the time of the report, VOMITING (vomiting), ARTHRALGIA (pain in her joints) and PYREXIA (fever) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Treatment information were not provided.  Concomitant medications were not provided.
Sex: U
Vaccine: COVID19
Symptoms: Arthralgia, Asthenia, Fatigue, Myalgia
Clinical narrative: No energy; Body aches; Joint aches; Tired; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of ASTHENIA (No energy), MYALGIA (Body aches), ARTHRALGIA (Joint aches) and FATIGUE (Tired) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 29-May-2021, the patient experienced ASTHENIA (No energy), MYALGIA (Body aches), ARTHRALGIA (Joint aches) and FATIGUE (Tired). At the time of the report, ASTHENIA (No energy), MYALGIA (Body aches), ARTHRALGIA (Joint aches) and FATIGUE (Tired) had not resolved.            No concomitant medications reported. No treatment medications reported.
Sex: U
Vaccine: COVID19
Symptoms: Product dose omission issue
Clinical narrative: I'm over 8 weeks over due for my second shot; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a patient and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (I'm over 8 weeks over due for my second shot) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE (I'm over 8 weeks over due for my second shot). At the time of the report, PRODUCT DOSE OMISSION ISSUE (I'm over 8 weeks over due for my second shot) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       no concomitant medications are provided. treatment to the evens not reported.   Reporter did not allow further contact
Sex: U
Vaccine: COVID19
Symptoms: Product dose omission issue
Clinical narrative: Late second dose; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (Late second dose) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. unknown) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE (Late second dose). At the time of the report, PRODUCT DOSE OMISSION ISSUE (Late second dose) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were reported.  No treatment medications were reported.
Sex: F
Vaccine: COVID19
Symptoms: Maternal exposure during pregnancy, Nausea, Vaccination site erythema, Vaccination site warmth
Clinical narrative: My arm warm at the injection site.; I feel nauseous; My arm is red at the injection site.; Received vaccine while pregnant; This spontaneous prospective pregnancy case was reported by a consumer and describes the occurrence of VACCINATION SITE WARMTH (My arm warm at the injection site.), MATERNAL EXPOSURE DURING PREGNANCY (Received vaccine while pregnant), NAUSEA (I feel nauseous) and VACCINATION SITE ERYTHEMA (My arm is red at the injection site.) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 28-May-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. Last menstrual period and estimated date of delivery were not provided. On 28-May-2021, the patient experienced MATERNAL EXPOSURE DURING PREGNANCY (Received vaccine while pregnant). On an unknown date, the patient experienced VACCINATION SITE WARMTH (My arm warm at the injection site.), NAUSEA (I feel nauseous) and VACCINATION SITE ERYTHEMA (My arm is red at the injection site.). On 28-May-2021, MATERNAL EXPOSURE DURING PREGNANCY (Received vaccine while pregnant) had resolved. At the time of the report, VACCINATION SITE WARMTH (My arm warm at the injection site.), NAUSEA (I feel nauseous) and VACCINATION SITE ERYTHEMA (My arm is red at the injection site.) outcome was unknown.            No concomitant medications were reported. Treatment information was not reported.   Most recent FOLLOW-UP information incorporated above includes: On 29-May-2021: Internal review on 22-Jul-2021 resulted in update to pregnancy information and second dose date.
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Chills, Myalgia
Clinical narrative: lots of joint pain; I had chills; I had lots of body ache/ my arm went sore; This spontaneous case was reported by a consumer and describes the occurrence of ARTHRALGIA (lots of joint pain), CHILLS (I had chills) and MYALGIA (I had lots of body ache/ my arm went sore) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 032L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 04-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Feb-2021, the patient experienced ARTHRALGIA (lots of joint pain), CHILLS (I had chills) and MYALGIA (I had lots of body ache/ my arm went sore). On 12-Feb-2021, ARTHRALGIA (lots of joint pain), CHILLS (I had chills) and MYALGIA (I had lots of body ache/ my arm went sore) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant medications included generic of Flonase for sinuses, vitamin C and vitamin D. Treatment information was not provided.
Sex: U
Vaccine: COVID19
Symptoms: Vaccination site warmth
Clinical narrative: Area where the shot was administered feels warm; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE WARMTH (Area where the shot was administered feels warm) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 vaccination.     No Medical History information was reported.    On 18-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 27-May-2021, the patient experienced VACCINATION SITE WARMTH (Area where the shot was administered feels warm). At the time of the report, VACCINATION SITE WARMTH (Area where the shot was administered feels warm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant product use was not provided by the reporter. Treatment information was not provided.
Sex: M
Vaccine: COVID19
Symptoms: Ageusia, Chills, Myalgia, Pyrexia, SARS-CoV-2 test
Clinical narrative: didn't have taste; fever; body aches; chills; COVID-19 diagnosis; This spontaneous case was reported by a consumer and describes the occurrence of AGEUSIA (didn't have taste), SARS-COV-2 TEST POSITIVE (COVID-19 diagnosis), PYREXIA (fever), MYALGIA (body aches) and CHILLS (chills) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 027C21A and 040B21A) for COVID-19 vaccination.     No Medical History information was reported.   On 09-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 08-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 29-May-2021, the patient experienced SARS-COV-2 TEST POSITIVE (COVID-19 diagnosis). On an unknown date, the patient experienced AGEUSIA (didn't have taste), PYREXIA (fever), MYALGIA (body aches) and CHILLS (chills). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency and IBUPROFEN (ADVIL [IBUPROFEN]) at an unspecified dose and frequency. At the time of the report, AGEUSIA (didn't have taste), SARS-COV-2 TEST POSITIVE (COVID-19 diagnosis), PYREXIA (fever), MYALGIA (body aches) and CHILLS (chills) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 29-May-2021, SARS-CoV-2 test: positive (Positive) got COVID-19 diagnosis.     For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Patient took Tylenol and Advil to alleviate the symptoms
Sex: M
Vaccine: COVID19
Symptoms: SARS-CoV-2 test positive
Clinical narrative: didn't have taste; fever; body aches; chills; COVID-19 diagnosis; This spontaneous case was reported by a consumer and describes the occurrence of AGEUSIA (didn't have taste), SARS-COV-2 TEST POSITIVE (COVID-19 diagnosis), PYREXIA (fever), MYALGIA (body aches) and CHILLS (chills) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 027C21A and 040B21A) for COVID-19 vaccination.     No Medical History information was reported.   On 09-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 08-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 29-May-2021, the patient experienced SARS-COV-2 TEST POSITIVE (COVID-19 diagnosis). On an unknown date, the patient experienced AGEUSIA (didn't have taste), PYREXIA (fever), MYALGIA (body aches) and CHILLS (chills). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency and IBUPROFEN (ADVIL [IBUPROFEN]) at an unspecified dose and frequency. At the time of the report, AGEUSIA (didn't have taste), SARS-COV-2 TEST POSITIVE (COVID-19 diagnosis), PYREXIA (fever), MYALGIA (body aches) and CHILLS (chills) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 29-May-2021, SARS-CoV-2 test: positive (Positive) got COVID-19 diagnosis.     For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Patient took Tylenol and Advil to alleviate the symptoms
Age: 79.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Influenza like illness, Vaccination site bruising, Vaccination site pain
Clinical narrative: Woke up dizzy; Pain; Bruise at injection site; Having flu like symptoms; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (Pain), VACCINATION SITE BRUISING (Bruise at injection site), INFLUENZA LIKE ILLNESS (Having flu like symptoms) and DIZZINESS (Woke up dizzy) in a 79-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 046A21A and 046A21A) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included ACETYLSALICYLIC ACID (ASPIRIN LOW).   On 29-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 27-May-2021, the patient experienced VACCINATION SITE PAIN (Pain), VACCINATION SITE BRUISING (Bruise at injection site) and INFLUENZA LIKE ILLNESS (Having flu like symptoms). On 28-May-2021, the patient experienced DIZZINESS (Woke up dizzy). At the time of the report, VACCINATION SITE PAIN (Pain), VACCINATION SITE BRUISING (Bruise at injection site), INFLUENZA LIKE ILLNESS (Having flu like symptoms) and DIZZINESS (Woke up dizzy) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) and mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.
Sex: U
Vaccine: COVID19
Symptoms: Skin exfoliation, Vaccination site haemorrhage, Vaccination site pain
Clinical narrative: skin the size of a dime is missing at vaccine injection area; It is still bleeding 4 hrs later; My 1st shot my arm burned; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of SKIN EXFOLIATION (skin the size of a dime is missing at vaccine injection area), VACCINATION SITE HAEMORRHAGE (It is still bleeding 4 hrs later) and VACCINATION SITE PAIN (My 1st shot my arm burned) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced SKIN EXFOLIATION (skin the size of a dime is missing at vaccine injection area), VACCINATION SITE HAEMORRHAGE (It is still bleeding 4 hrs later) and VACCINATION SITE PAIN (My 1st shot my arm burned). At the time of the report, SKIN EXFOLIATION (skin the size of a dime is missing at vaccine injection area), VACCINATION SITE HAEMORRHAGE (It is still bleeding 4 hrs later) and VACCINATION SITE PAIN (My 1st shot my arm burned) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medication provided. No treatment information provided.   Reporter did not allow further contact
Sex: U
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: fever; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (fever) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 27-May-2021, the patient experienced PYREXIA (fever). At the time of the report, PYREXIA (fever) outcome was unknown.            Concomitant medications were not reported.  Treatment medications was not given.
Sex: F
Vaccine: COVID19
Symptoms: Confusional state, Fatigue, Head discomfort, Headache, Illness
Clinical narrative: made me ill; experienced loose head; tingling on her body; confusion over 5 weeks; arm was weak; arm swelling; fatigue; headache; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of ILLNESS (made me ill), HEAD DISCOMFORT (experienced loose head), PARAESTHESIA (tingling on her body), CONFUSIONAL STATE (confusion over 5 weeks) and MUSCULAR WEAKNESS (arm was weak) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 017B21A and 031A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 15-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 15-Apr-2021, the patient experienced ILLNESS (made me ill), HEAD DISCOMFORT (experienced loose head), PARAESTHESIA (tingling on her body), CONFUSIONAL STATE (confusion over 5 weeks), MUSCULAR WEAKNESS (arm was weak), PERIPHERAL SWELLING (arm swelling), FATIGUE (fatigue) and HEADACHE (headache). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, ILLNESS (made me ill), HEAD DISCOMFORT (experienced loose head), PARAESTHESIA (tingling on her body), CONFUSIONAL STATE (confusion over 5 weeks), MUSCULAR WEAKNESS (arm was weak), PERIPHERAL SWELLING (arm swelling), FATIGUE (fatigue) and HEADACHE (headache) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Laboratory test: inconclusive (Inconclusive) Inconclusive.         No concomitant medications was provided.  Treatment medication were not provided.
Sex: F
Vaccine: COVID19
Symptoms: Laboratory test, Muscular weakness, Paraesthesia, Peripheral swelling
Clinical narrative: made me ill; experienced loose head; tingling on her body; confusion over 5 weeks; arm was weak; arm swelling; fatigue; headache; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of ILLNESS (made me ill), HEAD DISCOMFORT (experienced loose head), PARAESTHESIA (tingling on her body), CONFUSIONAL STATE (confusion over 5 weeks) and MUSCULAR WEAKNESS (arm was weak) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 017B21A and 031A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 15-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 15-Apr-2021, the patient experienced ILLNESS (made me ill), HEAD DISCOMFORT (experienced loose head), PARAESTHESIA (tingling on her body), CONFUSIONAL STATE (confusion over 5 weeks), MUSCULAR WEAKNESS (arm was weak), PERIPHERAL SWELLING (arm swelling), FATIGUE (fatigue) and HEADACHE (headache). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, ILLNESS (made me ill), HEAD DISCOMFORT (experienced loose head), PARAESTHESIA (tingling on her body), CONFUSIONAL STATE (confusion over 5 weeks), MUSCULAR WEAKNESS (arm was weak), PERIPHERAL SWELLING (arm swelling), FATIGUE (fatigue) and HEADACHE (headache) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Laboratory test: inconclusive (Inconclusive) Inconclusive.         No concomitant medications was provided.  Treatment medication were not provided.
Sex: U
Vaccine: COVID19
Symptoms: Breast pain, Nipple inflammation
Clinical narrative: breast pain; inflammation of the nipple; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of BREAST PAIN (breast pain) and NIPPLE INFLAMMATION (inflammation of the nipple) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced BREAST PAIN (breast pain) and NIPPLE INFLAMMATION (inflammation of the nipple). At the time of the report, BREAST PAIN (breast pain) and NIPPLE INFLAMMATION (inflammation of the nipple) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were reported. No treatment was reported.
Sex: U
Vaccine: COVID19
Symptoms: Fatigue
Clinical narrative: fatigue; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of FATIGUE (fatigue) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced FATIGUE (fatigue). At the time of the report, FATIGUE (fatigue) outcome was unknown.
Sex: U
Vaccine: COVID19
Symptoms: Cough
Clinical narrative: Coughing after taking a deep breath; This spontaneous case was reported by a consumer and describes the occurrence of COUGH (Coughing after taking a deep breath) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. unknown) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage form. On an unknown date, the patient experienced COUGH (Coughing after taking a deep breath). At the time of the report, COUGH (Coughing after taking a deep breath) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.       Reporter did not allow further contact
Sex: U
Vaccine: COVID19
Symptoms: Vaccination site erythema
Clinical narrative: a big red circle  came up on arm around the injection spot; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a patient and describes the occurrence of VACCINATION SITE ERYTHEMA (a big red circle  came up on arm around the injection spot) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE ERYTHEMA (a big red circle  came up on arm around the injection spot). At the time of the report, VACCINATION SITE ERYTHEMA (a big red circle  came up on arm around the injection spot) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Reporter did not allow further contact
Sex: U
Vaccine: COVID19
Symptoms: Viral load increased
Clinical narrative: Elevated viral load; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of VIRAL LOAD INCREASED (Elevated viral load) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VIRAL LOAD INCREASED (Elevated viral load). At the time of the report, VIRAL LOAD INCREASED (Elevated viral load) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       patient Six weeks after the second shot, patient vl is the highest since 1985. concomitant medications and treatment information was not provided by the reporter.
Sex: U
Vaccine: COVID19
Symptoms: Alopecia
Clinical narrative: hair loss; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of ALOPECIA (hair loss) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced ALOPECIA (hair loss). At the time of the report, ALOPECIA (hair loss) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were reported.  No treatment medications were reported.
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: Soreness in the arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Soreness in the arm) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 03-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 03-Mar-2021, the patient experienced PAIN IN EXTREMITY (Soreness in the arm). At the time of the report, PAIN IN EXTREMITY (Soreness in the arm) outcome was unknown.            Concomitant medications were not reported.  Treatment details were not reported.  Patient took second dose on 31-MAR-2021 in the left arm.
Age: 37.0
Sex: M
Vaccine: COVID19
Symptoms: Inappropriate schedule of product administration
Clinical narrative: a patient took 1st shot of moderna COVid-19 vaccine, last week 21MAY2021 and the second dose was given today 29MAY2021.; This spontaneous case was reported by a health care professional and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (a patient took 1st shot of moderna COVid-19 vaccine, last week 21MAY2021 and the second dose was given today 29MAY2021.) in a 37-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 037C21A and 037C21A) for COVID-19 vaccination.     No Medical History information was reported.   In May 2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 21-May-2021, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 28-May-2021, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (a patient took 1st shot of moderna COVid-19 vaccine, last week 21MAY2021 and the second dose was given today 29MAY2021.). On 28-May-2021, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (a patient took 1st shot of moderna COVid-19 vaccine, last week 21MAY2021 and the second dose was given today 29MAY2021.) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were reported.  No treatment medications were reported.  Action taken with mRNA-1273 in response to the events was not Applicable.
Sex: U
Vaccine: COVID19
Symptoms: Tooth infection
Clinical narrative: Tooth infection; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of TOOTH INFECTION (Tooth infection) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History was Provided by Reporter .     On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced TOOTH INFECTION (Tooth infection). The patient was treated with CLINDAMYCIN at an unspecified dose and frequency. At the time of the report, TOOTH INFECTION (Tooth infection) outcome was unknown.            Reporter did not allow further contact